Clinical Trials Browser

Phase 2 × Recurrence × trastuzumab deruxtecan × Clear all

NCT07340164 2026-01-14

TROY

Phase 2 Not yet recruiting

Ovarian Neoplasms, Recurrence

NCT05704829 2025-11-19

ADAPTHER2-IV

Phase 2 Active not recruiting

Recurrence